Discovery and development of Santacruzamate A, a potent and selective histone deacetylase inhibitor

被引：0

作者：

Balunas, M. J. ^{[1
,2
,3
,4
]}

Pavlik, C. M. ^{[1
]}

Wong, C. Y. B. ^{[4
]}

Lopez, D. D. ^{[4
]}

Engene, N. ^{[2
]}

McPhail, K. ^{[5
]}

Gerwick, W. H. ^{[2
,3
]}

机构：

[1] Univ Connecticut, Dept Pharmaceut Sci, Div Med Chem, Storrs, CT USA

[2] Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanog, La Jolla, CA 92093 USA

[3] Smithsonian Trop Res Inst, Panama City, Panama

[4] INDICASAT, Panama City, Panama

[5] Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA

来源：

PLANTA MEDICA | 2012年 / 78卷 / 11期

关键词：

D O I：

暂无

中图分类号：

Q94 [植物学];

学科分类号：

071001 ;

摘要：

引用

页码：1050 / 1050

页数：1

共 50 条

[41] Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries
Suzuki, Takayoshi
Ota, Yosuke
Ri, Masaki
Bando, Masashige
Gotoh, Aogu
Itoh, Yukihiro
Tsumoto, Hiroki
Tatum, Prima R.
Mizukami, Tamio
Nakagawa, Hidehiko
Iida, Shinsuke
Ueda, Ryuzo
Shirahige, Katsuhiko
Miyata, Naoki
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9562 - 9575
[42] Discovery of isozyme-selective histone deacetylase inhibitors by click chemistry
Suzuki, Takayoshi
Ota, Yosuke
Kasuya, Yuki
Nakagawa, Hidehiko
Miyata, Naoki
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
[43] Association of Valproic Acid Use, a Potent Histone Deacetylase Inhibitor, and Melanoma Risk
Chavez, Afton
Quesenberry, Charles P., Jr.
Darbinian, Jeanne
Asgari, Maryam M.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (12) : 2353 - 2358
[44] FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor
Nakajima, H
Kim, YB
Terano, H
Yoshida, M
Horinouchi, S
EXPERIMENTAL CELL RESEARCH, 1998, 241 (01) : 126 - 133
[45] Phage-assisted, active site-directed ligand evolution of a potent and selective histone deacetylase 8 inhibitor
Morse, Jared S. S.
Sheng, Yan J. J.
Hampton, Joshua Trae
Sylvain, Lauralee D. D.
Das, Sukant
Alugubelli, Yugendar R.
Chen, Peng-Hsun Chase
Yang, Kai S. S.
Xu, Shiqing
Fierke, Carol A. A.
Liu, Wenshe Ray
PROTEIN SCIENCE, 2022, 31 (12)
[46] Total synthesis of spiruchostatin B, a potent histone deacetylase inhibitor, from a microorganism
Takizawa, Toshiya
Watanabe, Kazuhiro
Narita, Koichi
Oguchi, Takamasa
Abe, Hideki
Katoh, Tadashi
CHEMICAL COMMUNICATIONS, 2008, (14) : 1677 - 1679
[47] Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1
Napper, AD
Hixon, J
McDonagh, T
Keavey, K
Pons, JF
Barker, J
Yau, WT
Amouzegh, P
Flegg, A
Hamelin, E
Thomas, RJ
Kates, M
Jones, S
Navia, MA
Saunders, J
DiStefano, PS
Curtis, R
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (25) : 8045 - 8054
[48] Process Development and Scale-up Total Synthesis of Largazole, a Potent Class I Histone Deacetylase Inhibitor
Chen, Qi-Yin
Chaturvedi, Pravin R.
Luesch, Hendrik
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2018, 22 (02) : 190 - 199
[49] Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors
Tsimberidou, Apostolia M.
Beer, Philip A.
Cartwright, Carrie A.
Haymaker, Cara
Vo, Henry H.
Kiany, Simin
Cecil, Alexander R. L.
Dow, James
Haque, Kemal
Silva, Franck A.
Coe, Lucy
Berryman, Helen
Bone, Elisabeth A.
Nogueras-Gonzalez, Graciela M.
Vining, David
McElwaine-Johnn, Hilary
Wistuba, Ignacio I.
CLINICAL CANCER RESEARCH, 2021, 27 (13) : 3584 - 3594
[50] Discovery of PAT-1102, a Novel, Potent and Orally Active Histone Deacetylase Inhibitor with Antitumor Activity in Cancer Mouse Models
Hiriyan, Jagadheshan
Shivarudraiah, Prasad
Gavara, Govindarajulu
Annamalai, Pazhanimuthu
Natesan, Selvakumar
Sambasivam, Ganesh
Sukumaran, Sunil K.
ANTICANCER RESEARCH, 2015, 35 (01) : 229 - 237

← 1 2 3 4 5 →